Department of Health and Human Services, Food and Drug Administration

Over-the-Counter Human Drugs and Labeling Requirements Gao ID: OGC-99-36 April 1, 1999

Pursuant to a legislative requirement, GAO reviewed the Food and Drug Administration's (FDA) new rule on over-the-counter human drugs and labeling requirements. GAO noted that: (1) the rule would establish a standardized format and standardized content requirements for the labeling of over-the-counter drug products; (2) the final rule has an announced effective date of April 16, 1999, which is less than the 60-day delay in a major rule's effective date required by the Small Business Regulatory Enforcement Fairness Act; and (3) FDA, with the exception of the failure to allow the 60-day delay, complied with the applicable requirements in promulgating the rule.



The Justia Government Accountability Office site republishes public reports retrieved from the U.S. GAO These reports should not be considered official, and do not necessarily reflect the views of Justia.